Renny, 680 mg+80 mg sugar-free mints 12 pcs

Pharmacodynamics

An antacid drug of local action. It contains calcium carbonate and magnesium carbonate, which provide fast and prolonged neutralization of excessive hydrochloric acid of gastric juice, thus providing a protective effect on the gastric mucosa.

The achievement of therapeutic effect within 3-5 minutes is due to the good solubility of the tablets and the high content of calcium.

Pharmacodynamics

Intake

As a result of interaction of Renny® with gastric juice in the stomach, soluble calcium and magnesium salts are formed. The level of absorption of calcium and magnesium from these compounds depends on the dose of the drug. The maximum level of absorption is 10% of calcium and 15-20% of magnesium.

Elimination

A small amount of absorbed calcium and magnesium is excreted by the kidneys. In the intestine, insoluble compounds are formed from soluble salts and excreted in the feces.

Pharmacokinetics in special clinical cases

In impaired renal function, plasma calcium and magnesium concentrations may increase.

Indications

Symptoms associated with hyperacidity of gastric juice and reflux esophagitis (including those caused by dietary irregularities, medication, alcohol, coffee, nicotine abuse): Heartburn, belching, intermittent stomach pain, feeling of fullness or heaviness in the epigastric region, flatulence, dyspepsia, dyspepsia of pregnant women.

Active ingredient

Composition

Active substances:

Calcium carbonate 680 mg;

Magnesium carbonate 80 mg.

Auxiliary substances:

sorbitol,

Pregelatinized corn starch,

potato starch,

talc,

magnesium stearate,

light paraffin,

mint flavoring,

sodium saccharinate.

How to take, the dosage

Adults and children over 12 years of age: Unless otherwise recommended by the doctor, if symptoms appear, chew 1-2 tablets or hold in the mouth until completely consumed.

May repeat if necessary after 2 hours.

The maximum daily dose is 16 tablets.

Interaction

Medicinal products should be taken 1-2 hours before or after taking antacid drugs.

In concomitant use Renny® reduces absorption of tetracycline antibiotics, fluoroquinolones, phosphates.

The anticholinergic drugs increase and prolong the effect of Renny®, slowing down gastric emptying.

When used concomitantly, Renny® increases the effects of sulfadiazine, levodopa, acetylsalicylic acid, and nalidixic acid.

Special Instructions

Use in renal dysfunction

The drug is contraindicated in severe renal failure. Patients with impaired renal function are not recommended to take the drug in high doses for a long time. While prescribing the drug in patients with impaired renal function, serum magnesium and calcium concentrations should be regularly monitored. Usage of Renny® in high doses may increase the risk of formation of kidney stones.

Impact on ability to drive vehicles and other activities requiring high concentration and speed of psychomotor reactions.

Contraindications

Side effects

Allergic reactions: in very rare cases rash, Quincke’s edema, anaphylactic reactions are possible.

The drug is well tolerated if the recommended doses are followed.

Overdose

Symptoms: worsening of the previously described side effects.

Treatment: symptomatic.

Pregnancy use

The drug is not harmful to the fetus or baby when used in the recommended doses.

Similarities